Skip to content
10-Q

Quarterly Report

UPSTREAM BIO, INC. UPB

0000950170-25-063957

← back to feed
Filed
May 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 53.79M sh
Short Term Investments Q1 2025 · Mar 31, 2025 $360.07M
Short Term Investments Q1 2025 · Dec 31, 2024 $144.56M
Current Liabilities Q1 2025 · Mar 31, 2025 $9.57M
Current Liabilities Q1 2025 · Dec 31, 2024 $10.74M
Total Liabilities Q1 2025 · Mar 31, 2025 $10.56M
Total Liabilities Q1 2025 · Dec 31, 2024 $11.87M
Current Assets Q1 2025 · Mar 31, 2025 $453.79M
Current Assets Q1 2025 · Dec 31, 2024 $479.16M
Total Assets Q1 2025 · Mar 31, 2025 $456.17M
Total Assets Q1 2025 · Dec 31, 2024 $481.72M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $325.89M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $31.51M
Shares Diluted Q1 2025 · Mar 31, 2024 3M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$17.56M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$133.41M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$123.13M
Eps Diluted Q1 2025 · Mar 31, 2024 −$4.68
Eps Basic Q1 2025 · Mar 31, 2024 −$4.68
Sga Expense Q1 2025 · Mar 31, 2024 $3.96M
Rd Expense Q1 2025 · Mar 31, 2024 $11.69M
Net Income Q1 2025 · Mar 31, 2024 −$10.89M
Operating Income Q1 2025 · Mar 31, 2024 −$15.01M
Revenue Q1 2025 · Mar 31, 2024 $640K